Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
|
|
Merck & Co., Inc. (MRK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 291 options to buy
@ $102.95, valued at
$30k
|
|
| 10/03/2023 |
4
| Seidman Christine E (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 79 options to buy
@ $102.95, valued at
$8.1k
|
|
| 10/03/2023 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 437 options to buy
@ $102.95, valued at
$45k
|
|
| 10/03/2023 |
4
| Coe Mary Ellen (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 291 options to buy
@ $102.95, valued at
$30k
|
|
| 08/15/2023 |
4
| MIZELL STEVEN (EVP, Chief HR Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 4,250 shares
@ $109.01, valued at
$463.3k
|
|
| 08/04/2023 |
4
| Guindo Chirfi (Chief Marketing Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 36,901 shares
@ $105.7, valued at
$3.9M
Paid exercise price by delivering 17,989 shares
@ $105.7, valued at
$1.9M
Exercised 36,901 restricted stock units
@ $0 |
|
| 08/04/2023 |
4
| MIZELL STEVEN (EVP, Chief HR Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 4,500 shares
@ $105.4891, valued at
$474.7k
|
|
| 08/03/2023 |
4
| Romanelli Joseph (President, Human Health Int?l) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 30 shares
@ $107.371, valued at
$3.2k
Sold 59 shares
@ $107.371, valued at
$6.3k
|
|
| 07/05/2023 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 260 options to buy
@ $115.39, valued at
$30k
|
|
| 07/05/2023 |
4
| Seidman Christine E (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 70 options to buy
@ $115.39, valued at
$8.1k
|
|
| 07/05/2023 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 390 options to buy
@ $115.39, valued at
$45k
|
|
| 07/05/2023 |
4
| Coe Mary Ellen (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 260 options to buy
@ $115.39, valued at
$30k
|
|
| 06/30/2023 |
4
| Romanelli Joseph (President, Human Health Int?l) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Bought 59 shares
@ $109.67, valued at
$6.5k
Bought 107 shares
@ $109.54, valued at
$11.7k
Bought 30 shares
@ $109.39, valued at
$3.3k
Bought 56 shares
@ $110.96, valued at
$6.2k
Bought 7 shares
@ $109.04, valued at
$763.3
Bought 11 shares
@ $109.2, valued at
$1.2k
Bought 136 shares
@ $105.47, valued at
$14.3k
Sold 35 shares
@ $104.65, valued at
$3.7k
Bought 3 shares
@ $113.68, valued at
$341 |
|
| 05/31/2023 |
4
| LAVIZZO-MOUREY RISA J (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/31/2023 |
4
| THULIN INGE G (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/31/2023 |
4
| WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/31/2023 |
4
| Warden Kathy J (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/31/2023 |
4
| Seidman Christine E (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/31/2023 |
4
| RUSSO PATRICIA F (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/31/2023 |
4
| Rothman Paul (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/31/2023 |
4
| Mayo Stephen (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/31/2023 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/31/2023 |
4
| Craig Pamela J. (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/31/2023 |
4
| Coe Mary Ellen (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/31/2023 |
4
| BAKER DOUGLAS M JR (Director) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
| 05/05/2023 |
4
| MIZELL STEVEN (EVP, Chief HR Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 13,000 shares
@ $77.62, valued at
$1M
Exercised 15,000 shares
@ $75.36, valued at
$1.1M
Exercised 12,000 shares
@ $73.73, valued at
$884.8k
Sold 13,000 shares
@ $119.0086, valued at
$1.5M
Sold 15,000 shares
@ $119.0081, valued at
$1.8M
Sold 12,000 shares
@ $119.0074, valued at
$1.4M
Exercised 12,000 shares
@ $75.36, valued at
$904.3k
Sold 13,400 shares
@ $119.01, valued at
$1.6M
Exercised 13,000 options to buy
@ $0
Exercised 12,000 options to buy
@ $0
Exercised 15,000 options to buy
@ $0 |
|
| 05/05/2023 |
4
| Zachary Jennifer (EVP, General Counsel) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 19,141 shares
@ $117.5923, valued at
$2.3M
|
|
| 05/05/2023 |
4
| Oosthuizen Johannes Jacobus (President, U.S. Market) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 907 shares
@ $118.22, valued at
$107.2k
Paid exercise price by delivering 447 shares
@ $118.22, valued at
$52.8k
Exercised 907 restricted stock units
@ $0 |
|
| 05/05/2023 |
4
| Klobuchar Michael A (EVP - Chief Strategy Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 885 shares
@ $118.22, valued at
$104.6k
Paid exercise price by delivering 436 shares
@ $118.22, valued at
$51.5k
Exercised 885 restricted stock units
@ $0 |
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2023 |
4
| Karachun Rita A (Sr. VP Fince-Global Controller) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 803 shares
@ $117.89, valued at
$94.7k
Paid exercise price by delivering 276 shares
@ $117.89, valued at
$32.5k
Exercised 949 shares
@ $118.22, valued at
$112.2k
Paid exercise price by delivering 326 shares
@ $118.22, valued at
$38.5k
Sold 15,875 shares
@ $117.5334, valued at
$1.9M
Exercised 803 restricted stock units
@ $0
Exercised 949 restricted stock units
@ $0
Exercised 15,875 options to buy
@ $62.07, valued at
$985.4k
|
|
| 05/04/2023 |
4
| LeCointe-Cephas Lisa (SVP Chief Ethics & Com Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 9,682 options to buy
@ $117.89, valued at
$1.1M
Granted 1,781 restricted stock units
@ $0 |
|
| 05/04/2023 |
4
| Karachun Rita A (Sr. VP Fince-Global Controller) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 9,682 options to buy
@ $117.89, valued at
$1.1M
Granted 1,781 restricted stock units
@ $0 |
|
| 05/04/2023 |
4
| Litchfield Caroline (EVP & CFO) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 58,783 options to buy
@ $117.89, valued at
$6.9M
|
|
|
|
|